99 related articles for article (PubMed ID: 1731463)
1. Hemodynamic and metabolic effects of intravenous clentiazem in hypertensive patients.
Frohlich ED; McLoughlin M; Ketelhut R
Am J Cardiol; 1992 Jan; 69(3):229-32. PubMed ID: 1731463
[TBL] [Abstract][Full Text] [Related]
2. Immediate and short-term hemodynamic effects of diltiazem in patients with hypertension.
Amodeo C; Kobrin I; Ventura HO; Messerli FH; Frohlich ED
Circulation; 1986 Jan; 73(1):108-13. PubMed ID: 3510085
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics and pharmacokinetics of clentiazem and diltiazem in closed-chest anesthetized dogs.
Giasson S; Garceau D; Homsy W; Dumont L
Cardiovasc Drugs Ther; 1995 Oct; 9(5):685-92. PubMed ID: 8573551
[TBL] [Abstract][Full Text] [Related]
4. Effect of clentiazem on arterial pressure and renal function in normotensive and hypertensive rats.
Fenoy FJ; Milicic I; Mistry M; Mecca TE; Roman RJ
J Pharmacol Exp Ther; 1992 May; 261(2):470-5. PubMed ID: 1578362
[TBL] [Abstract][Full Text] [Related]
5. Effects of diltiazem on hormonal and hemodynamic responses to lower body negative pressure and tilt in patients with mild to moderate systemic hypertension.
Mohanty PK; Sowers JR; McNamara C; Welch B; Beck F; Thames MD
Am J Cardiol; 1985 Dec; 56(16):28H-33H. PubMed ID: 3907320
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of Ro 23-6152 in patients with essential hypertension.
Folkers HB; van Zwienen JC; Boer P; Kleinbloesem CH; Geyskes GG
Eur J Clin Pharmacol; 1991; 41(4):307-11. PubMed ID: 1804644
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the daily variation in blood pressure and pharmacokinetics after single or repeated administration of clentiazem to patients with essential hypertension.
Suzuki S; Mori M; Kusano S
Arzneimittelforschung; 1992 Apr; 42(4):533-9. PubMed ID: 1642678
[TBL] [Abstract][Full Text] [Related]
8. Vasoconstriction during acute hypervolemic hemodilution in hypertensive patients is not prevented by calcium blockade.
Wysocki M; Andersson OK; Persson B; Bagge U
Angiology; 1998 Jan; 49(1):41-8. PubMed ID: 9456163
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of clentiazem in patients with essential hypertension: results of an early pilot test.
Kawakita S; Kinoshita M; Ishikawa H; Kagoshima T; Katori R; Ishikawa K; Hirota Y
Clin Cardiol; 1991 Jan; 14(1):53-60. PubMed ID: 2019030
[TBL] [Abstract][Full Text] [Related]
10. [Comparative hemodynamic effects of 2 vasodilators: dihydralazine and diltiazem in permanent essential arterial hypertension].
Levenson J; Simon A; Achimastos A; Temmar M; Safar M
Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():167-70. PubMed ID: 6810821
[TBL] [Abstract][Full Text] [Related]
11. Natriuretic effect of calcium-channel blockers in hypertensives.
Krishna GG; Riley LJ; Deuter G; Kapoor SC; Narins RG
Am J Kidney Dis; 1991 Nov; 18(5):566-72. PubMed ID: 1951336
[TBL] [Abstract][Full Text] [Related]
12. Increased sensitivity to diltiazem hypotensive effect in an experimental model of high-renin hypertension.
Bertera FM; Mayer MA; Opezzo JA; Taira CA; Höcht C
J Pharm Pharmacol; 2009 Jan; 61(1):79-87. PubMed ID: 19126300
[TBL] [Abstract][Full Text] [Related]
13. Role of calcium antagonists in the treatment of essential hypertension.
Klein W; Brandt D; Vrecko K; Härringer M
Circ Res; 1983 Feb; 52(2 Pt 2):I174-81. PubMed ID: 6831651
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic and humoral effects of intravenous dilevalol in patients with moderate hypertension.
Grossman E; Messerli FH; Oren S; MacPhee AA
Am J Cardiol; 1989 Jun; 63(19):34I-37I. PubMed ID: 2524958
[TBL] [Abstract][Full Text] [Related]
15. [Acute treatment of arterial hypertension using calcium antagonists: comparison between diltiazem and nifedipine].
Arigoni C; Rusca A; Pusterla CE; Beretta-Piccoli C
Schweiz Med Wochenschr; 1987 Jul; 117(30):1152-7. PubMed ID: 3313686
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive and hemodynamic effects of calcium channel blockade with isradipine after acute exercise.
Cléroux J; Yardley C; Marshall A; Coulombe D; Lacourcière Y
Am J Hypertens; 1992 Feb; 5(2):84-7. PubMed ID: 1532316
[TBL] [Abstract][Full Text] [Related]
17. The role of calcium entry blockers in hypertensive emergencies.
Bauer JH; Reams GP
Circulation; 1987 Jun; 75(6 Pt 2):V174-80. PubMed ID: 3552314
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic changes associated with long-term antihypertensive therapy with new calcium antagonist.
Fujita T; Noda H
Jpn Heart J; 1983 Jul; 24(4):587-93. PubMed ID: 6417370
[TBL] [Abstract][Full Text] [Related]
19. The role of renal hemodynamics in the antihypertensive action of mepirodipine, a new calcium antagonist.
Noda H; Fujita T; Ogata E
Jpn Circ J; 1992 Jan; 56(1):21-6. PubMed ID: 1538573
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy.
Ibrahim MM; el-Boghdadly B; Zaghloul SS
J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
